Bode AM - Search Results

1

Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities.

Liu Q, Bode AM, Chen X, Luo X. Liu Q, et al. Among authors: bode am. Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):189023. doi: 10.1016/j.bbcan.2023.189023. Epub 2023 Nov 16. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37979733 Review.

2

Correction: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance.

Xie L, Shi F, Li Y, Li W, Yu X, Zhao L, Zhou M, Hu J, Luo X, Tang M, Fan J, Zhou J, Gao Q, Wu W, Zhang X, Liao W, Bode AM, Cao Y. Xie L, et al. Among authors: bode am. Signal Transduct Target Ther. 2022 Dec 20;7(1):398. doi: 10.1038/s41392-022-01261-y. Signal Transduct Target Ther. 2022. PMID: 36539397 Free PMC article. No abstract available.

3

Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.

Liao C, Li M, Chen X, Tang C, Quan J, Bode AM, Cao Y, Luo X. Liao C, et al. Among authors: bode am. J Exp Clin Cancer Res. 2023 Oct 7;42(1):261. doi: 10.1186/s13046-023-02835-6. J Exp Clin Cancer Res. 2023. PMID: 37803433 Free PMC article.

4

CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma.

Li Y, Yang C, Xie L, Shi F, Tang M, Luo X, Liu N, Hu X, Zhu Y, Bode AM, Gao Q, Zhou J, Fan J, Li X, Cao Y. Li Y, et al. Among authors: bode am. Cell Death Dis. 2024 Jan 29;15(1):95. doi: 10.1038/s41419-024-06419-w. Cell Death Dis. 2024. PMID: 38287022 Free PMC article.

5

Targeting CDK1 in cancer: mechanisms and implications.

Wang Q, Bode AM, Zhang T. Wang Q, et al. Among authors: bode am. NPJ Precis Oncol. 2023 Jun 13;7(1):58. doi: 10.1038/s41698-023-00407-7. NPJ Precis Oncol. 2023. PMID: 37311884 Free PMC article. Review.

6

Endometriosis: Cell Death and Cell Signaling Machinery.

Carbone G, Nelson K, Baumgartner C, Bode AM, Takahashi A, Chefetz I. Carbone G, et al. Among authors: bode am. Endocrinology. 2023 Apr 17;164(6):bqad057. doi: 10.1210/endocr/bqad057. Endocrinology. 2023. PMID: 37216932 Review.

7

Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032.

Eedara BB, Manivannan B, Alabsi W, Sun B, Curiel-Lewandrowski C, Zhang T, Bode AM, Mansour HM. Eedara BB, et al. Among authors: bode am. Int J Mol Sci. 2023 Oct 24;24(21):15515. doi: 10.3390/ijms242115515. Int J Mol Sci. 2023. PMID: 37958502 Free PMC article.

8

Fyn-mediated phosphorylation of Menin disrupts telomere maintenance in stem cells.

Paul S, McCourt PM, Le LTM, Ryu J, Czaja W, Bode AM, Contreras-Galindo R, Dong Z. Paul S, et al. Among authors: bode am. bioRxiv [Preprint]. 2024 Mar 19:2023.10.04.560876. doi: 10.1101/2023.10.04.560876. bioRxiv. 2024. PMID: 37873235 Free PMC article. Preprint.

9

Recent Advances in Carcinogenesis Transcription Factors: Biomarkers and Targeted Therapies.

Bode AM, Zhang T. Bode AM, et al. Cancers (Basel). 2023 Sep 22;15(19):4673. doi: 10.3390/cancers15194673. Cancers (Basel). 2023. PMID: 37835367 Free PMC article.

10

Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation.

Ruiz VH, Encinas-Basurto D, Sun B, Eedara BB, Roh E, Alarcon NO, Curiel-Lewandrowski C, Bode AM, Mansour HM. Ruiz VH, et al. Among authors: bode am. Int J Mol Sci. 2023 May 15;24(10):8776. doi: 10.3390/ijms24108776. Int J Mol Sci. 2023. PMID: 37240122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page